Product Name :
Ralaniten triacetate
Description:
Ralaniten triacetate (EPI-506), the pro-drug of Ralaniten, is a first-in-class, orally active androgen receptor (AR) N-terminal domain (NTD) inhibitor. Ralaniten triacetate shows activity against both full length and resistance-related AR species, including AR-v7.
CAS:
1637573-04-6
Molecular Weight:
521.00
Formula:
C27H33ClO8
Chemical Name:
(2S)-1-(acetyloxy)-3-[4-(2-{4-[(2S)-2-(acetyloxy)-3-chloropropoxy]phenyl}propan-2-yl)phenoxy]propan-2-yl acetate
Smiles :
CC(=O)OC[C@H](COC1C=CC(=CC=1)C(C)(C)C1C=CC(=CC=1)OC[C@@H](CCl)OC(C)=O)OC(C)=O
InChiKey:
HGHVYYKTOXUQNT-CLJLJLNGSA-N
InChi :
InChI=1S/C27H33ClO8/c1-18(29)32-16-26(36-20(3)31)17-34-24-12-8-22(9-13-24)27(4,5)21-6-10-23(11-7-21)33-15-25(14-28)35-19(2)30/h6-13,25-26H,14-17H2,1-5H3/t25-,26-/m1/s1
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥12 months if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
Ralaniten triacetate (EPI-506), the pro-drug of Ralaniten, is a first-in-class, orally active androgen receptor (AR) N-terminal domain (NTD) inhibitor. Ralaniten triacetate shows activity against both full length and resistance-related AR species, including AR-v7.|Product information|CAS Number: 1637573-04-6|Molecular Weight: 521.00|Formula: C27H33ClO8|Chemical Name: (2S)-1-(acetyloxy)-3-[4-(2-{4-[(2S)-2-(acetyloxy)-3-chloropropoxy]phenyl}propan-2-yl)phenoxy]propan-2-yl acetate|Smiles: CC(=O)OC[C@H](COC1C=CC(=CC=1)C(C)(C)C1C=CC(=CC=1)OC[C@@H](CCl)OC(C)=O)OC(C)=O|InChiKey: HGHVYYKTOXUQNT-CLJLJLNGSA-N|InChi: InChI=1S/C27H33ClO8/c1-18(29)32-16-26(36-20(3)31)17-34-24-12-8-22(9-13-24)27(4,5)21-6-10-23(11-7-21)33-15-25(14-28)35-19(2)30/h6-13,25-26H,14-17H2,1-5H3/t25-,26-/m1/s1|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Solubility: DMSO : 100 mg/mL (191.{{Famoxadone} web|{Famoxadone} Anti-infection|{Famoxadone} Immunology/Inflammation|{Famoxadone} Protocol|{Famoxadone} Description|{Famoxadone} manufacturer} 94 mM; Need ultrasonic).{{Sevelamer} medchemexpress|{Sevelamer} Metabolic Enzyme/Protease|{Sevelamer} Biological Activity|{Sevelamer} In stock|{Sevelamer} manufacturer|{Sevelamer} Epigenetics} |Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.PMID:32644336 |Shelf Life: ≥12 months if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|How to use|In Vitro:|Ralaniten triacetate (EPI-506) targets the N-terminal domain of the androgen receptor (AR), and is used for metastatic castration-resistant prostate cancer (mCRPC) research. EPI-506 is a first-in-class, highly-specific small molecule that binds to a novel target on the AR, the N-terminal domain (NTD) and directly inhibits AR transcriptional activity by blocking the interaction of the AR with transcriptional proteins.|Products are for research use only. Not for human use.|